- Home
- ARWR vs NWN Comparison
ARWR vs NWN Comparison
Compare ARWR & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- NWN
- Stock Information
- Founded
- ARWR 2003
- NWN 1859
- Country
- ARWR United States
- NWN United States
- Employees
- ARWR N/A
- NWN N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- NWN Oil/Gas Transmission
- Sector
- ARWR Health Care
- NWN Utilities
- Exchange
- ARWR Nasdaq
- NWN Nasdaq
- Market Cap
- ARWR 1.8B
- NWN 1.6B
- IPO Year
- ARWR 1993
- NWN N/A
- Fundamental
- Price
- ARWR $16.29
- NWN $39.77
- Analyst Decision
- ARWR Buy
- NWN Buy
- Analyst Count
- ARWR 8
- NWN 2
- Target Price
- ARWR $43.71
- NWN $48.00
- AVG Volume (30 Days)
- ARWR 2.0M
- NWN 264.7K
- Earning Date
- ARWR 08-07-2025
- NWN 08-05-2025
- Dividend Yield
- ARWR N/A
- NWN 4.93%
- EPS Growth
- ARWR N/A
- NWN 17.48
- EPS
- ARWR N/A
- NWN 2.58
- Revenue
- ARWR $545,209,000.00
- NWN $1,238,288,000.00
- Revenue This Year
- ARWR $22,384.93
- NWN $16.91
- Revenue Next Year
- ARWR N/A
- NWN $6.75
- P/E Ratio
- ARWR N/A
- NWN $15.40
- Revenue Growth
- ARWR 1436.97
- NWN 8.40
- 52 Week Low
- ARWR $9.57
- NWN $37.41
- 52 Week High
- ARWR $27.34
- NWN $44.38
- Technical
- Relative Strength Index (RSI)
- ARWR 49.29
- NWN 40.48
- Support Level
- ARWR $15.83
- NWN $39.29
- Resistance Level
- ARWR $16.73
- NWN $40.72
- Average True Range (ATR)
- ARWR 0.87
- NWN 0.66
- MACD
- ARWR -0.02
- NWN -0.19
- Stochastic Oscillator
- ARWR 73.75
- NWN 12.50
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About NWN Northwest Natural Holding Company
Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.